Organ transplantation has witnessed rapid technological advancements over the past two decades and has become one of the proffered choices for patients suffering from critical illness owing to end-stage organ disease. Despite of constant appeal from the hospitals, government and healthcare institutes, the number of organ donators is low and growing at low pace. This makes it very important to well preserve whichever organs are received from donors for the benefits of patients waiting for the same. In doing so, organ preservation is of very critical importance and need to be carried out carefully. Organ preservation is very important to keep function and tissue of organs intact until it gets transplanted into receiver’s body. Global Organ Preservatives Market was valued at around USD 22 million in 2019 and expected to grow at a CAGR of over 12.8% to reach over USD 427 million in 2027.
The growing elderly population provides huge opportunities for healthcare providers to increase their market share. In 2019, an estimated 1billion people were aged 60 or older—8 percent of the world’s population. By 2050, this number is expected to nearly triple to about 2 billion, representing 15 percent of the world’s population. Although more developed countries have the oldest population profiles, the vast majority of older people—and the most rapidly aging populations—are in less developed countries. Between 2010 and 2050, the number of older people in less developed countries is projected to increase more than 250 percent, compared with a 71 percent increase in developed countries. The elderly are more susceptible to chronic diseases and organ failures due to many reasons. So an increase in the aging population leads to a higher prevalence of organ transplantation. Therefore, the demand for organ preservatives is expected to shoot up in the years to come.
Download Free Sample Report @ https://www.eonmarketresearch.com/sample/77317
By type, global Organ Preservatives market is segmented into Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution, PERFADEX, HypoThermosol, Others (Lifor, Human BioSystems (HBS) Solution, siRNA Transplant Solutions, etc.). Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution dominated the global primary hyperoxaluria drugs market with over 40% share in 2019. It is also expected to exhibit fastest CAGR during the forecast period.
By preservation technique, global Organ Preservatives market is segmented into Hypothermic Perfusion Preservation (HPP), Static Cold Storage (SCS) and Others. Static Cold Storage (SCS) segment dominated the global primary hyperoxaluria drug market with over 45% share in 2019. Demand for clinics is also expected to exhibit the fastest CAGR over the forecast period. However, High cost of organ transplantation is resulted into a major setback for organ preservatives market.
Global Organ Preservatives market is dominated by the Europe. Europe accounted for over 40% share in 2019. Large number of donors due to widespread awareness among people regarding organ donations and deep penetration of organ preservation facilities supported and funded by government are major growth driving factor for this industry in the region. However, Asia Pacific is also expected to advance at a rapid CAGR during the forecast period.
Major companies analyzed in the report include but not limited to Dr. Franz Köhler Chemie GmbH, Bristol-Myers Squibb, XVIVO Perfusion AB, Teva Pharmaceutical Industries Ltd., BioLife Solutions and Others. Global Organ Preservatives market is moderately fragmented with few handfuls of large companies. Top five companies accounted for one third share in total revenue generated by this industry.
Buy This Premium Report: https://www.eonmarketresearch.com/buy/77317
Segmentation:
Organ Preservatives Market by Solution, 2015 – 2027 Revenue (USD Million)
• Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution
• PERFADEX
• HypoThermosol
• Others (Lifor, Human BioSystems (HBS) Solution, siRNA Transplant Solutions, etc.)
Organ Preservatives Market by Preservation Technique, 2015 – 2027 Revenue (USD Million)
• Hypothermic Perfusion Preservation (HPP)
• Static Cold Storage (SCS)
• Others
Organ Preservatives Market by Region, 2015 – 2027 Revenue (USD Million)
• North America
o United States
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Russia
o Italy
o Spain
• Asia Pacific
o China
o Japan
o South Korea
o India
o Southeast Asia
o Australia
• Latin America
o Brazil
o Argentina
o Chile
o Peru
• Middle East and Africa
o Egypt
o Saudi Arabia
o South Africa
o Turkey
o Israel
Organ Preservatives Market by Company, 2018 – 2019 Revenue (USD Million)
• Dr. Franz Köhler Chemie GmbH
• Bristol-Myers Squibb
• XVIVO Perfusion AB
• Teva Pharmaceutical Industries Ltd.
• BioLife Solutions
• Others
Do Inquiry Before Purchasing Report Here and Ask For Discount: https://www.eonmarketresearch.com/enquiry/77317
Explore Related Reports:
- Global Optical DTI Imaging Technology Market
- Global Choline Alfoscerate (Alpha GPC) Market
- Global Bovine Ephemeral Fever Vaccines Market
- Global Cartilage Repair Regeneration Market
- Global Melatonin Market
- Global Liraglutide Injection Market
About Us:
Eon Market Research (EMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers.
Contact Us:
Eon Market Research
Phone: +1 703 879 7090
Email: sales@eonmarketresearch.com
